Feature  ||| S:0 E:8 ||| NNP
Tracking-Derived  ||| S:8 E:25 ||| NNP
Peak  ||| S:25 E:30 ||| NNP
Systolic  ||| S:30 E:39 ||| NNP
Strain  ||| S:39 E:46 ||| NNP
Compared  ||| S:46 E:55 ||| NNP
to  ||| S:55 E:58 ||| TO
Late  ||| S:58 E:63 ||| NNP
Gadolinium  ||| S:63 E:74 ||| NNP
Enhancement  ||| S:74 E:86 ||| NNP
in  ||| S:86 E:89 ||| IN
Troponin-Positive  ||| S:89 E:107 ||| NNP
Myocarditis ||| S:107 E:118 ||| NNP
:  ||| S:118 E:120 ||| :
A  ||| S:120 E:122 ||| DT
Case-Control  ||| S:122 E:135 ||| JJ
Study  ||| S:135 E:141 ||| NNP
Cardiac  ||| S:141 E:149 ||| NNP
magnetic  ||| S:149 E:158 ||| JJ
resonance  ||| S:158 E:168 ||| NN
( ||| S:168 E:169 ||| -LRB-
CMR ||| S:169 E:172 ||| NNP
)  ||| S:172 E:174 ||| -RRB-
assesses  ||| S:174 E:183 ||| FW
myocardial  ||| S:183 E:194 ||| FW
involvement  ||| S:194 E:206 ||| FW
in  ||| S:206 E:209 ||| FW
myocarditis  ||| S:209 E:221 ||| FW
( ||| S:221 E:222 ||| -LRB-
MYO ||| S:222 E:225 ||| NNP
) ||| S:225 E:226 ||| -RRB-
.  ||| S:226 E:228 ||| .
Current  ||| S:228 E:236 ||| JJ
techniques  ||| S:236 E:247 ||| NNS
are  ||| S:247 E:251 ||| VBP
qualitative ||| S:251 E:262 ||| VBN
,  ||| S:262 E:264 ||| ,
subjective ||| S:264 E:274 ||| JJ
,  ||| S:274 E:276 ||| ,
and  ||| S:276 E:280 ||| CC
prone  ||| S:280 E:286 ||| JJ
to  ||| S:286 E:289 ||| TO
interpretation  ||| S:289 E:304 ||| NN
error ||| S:304 E:309 ||| NN
.  ||| S:309 E:311 ||| .
Feature  ||| S:311 E:319 ||| NN
tracking  ||| S:319 E:328 ||| NN
( ||| S:328 E:329 ||| -LRB-
FT ||| S:329 E:331 ||| NNP
)  ||| S:331 E:333 ||| -RRB-
analyzes  ||| S:333 E:342 ||| JJ
myocardial  ||| S:342 E:353 ||| NNS
strain  ||| S:353 E:360 ||| VBP
using  ||| S:360 E:366 ||| VBG
CMR  ||| S:366 E:370 ||| NNP
and  ||| S:370 E:374 ||| CC
has  ||| S:374 E:378 ||| VBZ
not  ||| S:378 E:382 ||| RB
been  ||| S:382 E:387 ||| VBN
examined  ||| S:387 E:396 ||| VBN
in  ||| S:396 E:399 ||| IN
MYO ||| S:399 E:402 ||| NNP
.  ||| S:402 E:404 ||| .
We  ||| S:404 E:407 ||| PRP
hypothesize  ||| S:407 E:419 ||| VBD
that  ||| S:419 E:424 ||| DT
regional  ||| S:424 E:433 ||| JJ
left  ||| S:433 E:438 ||| JJ
ventricular  ||| S:438 E:450 ||| NNS
( ||| S:450 E:451 ||| -LRB-
LV ||| S:451 E:453 ||| NNP
)  ||| S:453 E:455 ||| -RRB-
strain  ||| S:455 E:462 ||| NN
is  ||| S:462 E:465 ||| VBZ
abnormal  ||| S:465 E:474 ||| VBN
in  ||| S:474 E:477 ||| IN
MYO ||| S:477 E:480 ||| NNP
.  ||| S:480 E:482 ||| .
Regional  ||| S:482 E:491 ||| JJ
strain  ||| S:491 E:498 ||| NN
by  ||| S:498 E:501 ||| IN
FT  ||| S:501 E:504 ||| NNP
was  ||| S:504 E:508 ||| VBD
compared  ||| S:508 E:517 ||| VBN
to  ||| S:517 E:520 ||| TO
late  ||| S:520 E:525 ||| JJ
gadolinium  ||| S:525 E:536 ||| JJ
enhancement  ||| S:536 E:548 ||| NN
( ||| S:548 E:549 ||| -LRB-
LGE ||| S:549 E:552 ||| NNP
)  ||| S:552 E:554 ||| -RRB-
and  ||| S:554 E:558 ||| CC
troponin  ||| S:558 E:567 ||| JJ
leak  ||| S:567 E:572 ||| NN
as  ||| S:572 E:575 ||| IN
measures  ||| S:575 E:584 ||| NNS
of  ||| S:584 E:587 ||| IN
myocardial  ||| S:587 E:598 ||| JJ
involvement ||| S:598 E:609 ||| NN
.  ||| S:609 E:611 ||| .
This  ||| S:611 E:616 ||| DT
single-center ||| S:616 E:629 ||| JJ
,  ||| S:629 E:631 ||| ,
retrospective  ||| S:631 E:645 ||| JJ
CMR  ||| S:645 E:649 ||| NNS
study  ||| S:649 E:655 ||| VBP
reviewed  ||| S:655 E:664 ||| VBN
patients  ||| S:664 E:673 ||| NNS
with  ||| S:673 E:678 ||| IN
clinical  ||| S:678 E:687 ||| JJ
MYO  ||| S:687 E:691 ||| NNP
and  ||| S:691 E:695 ||| CC
structurally  ||| S:695 E:708 ||| RB
normal  ||| S:708 E:715 ||| JJ
hearts  ||| S:715 E:722 ||| NNS
who  ||| S:722 E:726 ||| WP
underwent  ||| S:726 E:736 ||| VBD
CMR  ||| S:736 E:740 ||| NNP
at  ||| S:740 E:743 ||| IN
our  ||| S:743 E:747 ||| PRP$
institution ||| S:747 E:758 ||| NN
.  ||| S:758 E:760 ||| .
Young  ||| S:760 E:766 ||| JJ
adults  ||| S:766 E:773 ||| NNS
with  ||| S:773 E:778 ||| IN
normal  ||| S:778 E:785 ||| JJ
cardiac  ||| S:785 E:793 ||| JJ
anatomy ||| S:793 E:800 ||| NN
,  ||| S:800 E:802 ||| ,
function ||| S:802 E:810 ||| NN
,  ||| S:810 E:812 ||| ,
and  ||| S:812 E:816 ||| CC
absent  ||| S:816 E:823 ||| JJ
LGE  ||| S:823 E:827 ||| NNP
served  ||| S:827 E:834 ||| VBD
as  ||| S:834 E:837 ||| IN
controls ||| S:837 E:845 ||| NNS
.  ||| S:845 E:847 ||| .
MYO  ||| S:847 E:851 ||| NNP
patients  ||| S:851 E:860 ||| NNS
with  ||| S:860 E:865 ||| IN
documented  ||| S:865 E:876 ||| JJ
troponin  ||| S:876 E:885 ||| JJ
leak  ||| S:885 E:890 ||| NN
and  ||| S:890 E:894 ||| CC
normal  ||| S:894 E:901 ||| JJ
global  ||| S:901 E:908 ||| JJ
ejection  ||| S:908 E:917 ||| JJ
fraction  ||| S:917 E:926 ||| NN
( ||| S:926 E:927 ||| -LRB-
EF  ||| S:927 E:930 ||| CD
> ||| S:930 E:931 ||| CD
 50  ||| S:931 E:935 ||| CD
% ||| S:935 E:936 ||| NN
)  ||| S:936 E:938 ||| -RRB-
were  ||| S:938 E:943 ||| VBD
included  ||| S:943 E:952 ||| VBN
in  ||| S:952 E:955 ||| IN
comparison ||| S:955 E:965 ||| NN
.  ||| S:965 E:967 ||| .
FT  ||| S:967 E:970 ||| NNP
determined  ||| S:970 E:981 ||| VBD
regional  ||| S:981 E:990 ||| JJ
myocardial  ||| S:990 E:1001 ||| JJ
peak  ||| S:1001 E:1006 ||| NN
systolic  ||| S:1006 E:1015 ||| NN
strain  ||| S:1015 E:1022 ||| NN
( ||| S:1022 E:1023 ||| -LRB-
pkS ||| S:1023 E:1026 ||| NNP
)  ||| S:1026 E:1028 ||| -RRB-
in  ||| S:1028 E:1031 ||| IN
longitudinal  ||| S:1031 E:1044 ||| NN
and  ||| S:1044 E:1048 ||| CC
circumferential  ||| S:1048 E:1064 ||| JJ
distributions ||| S:1064 E:1077 ||| NNS
.  ||| S:1077 E:1079 ||| .
T  ||| S:1079 E:1081 ||| NN
tests  ||| S:1081 E:1087 ||| NNS
compared  ||| S:1087 E:1096 ||| VBN
strain  ||| S:1096 E:1103 ||| NN
values  ||| S:1103 E:1110 ||| NNS
between  ||| S:1110 E:1118 ||| IN
cases  ||| S:1118 E:1124 ||| NNS
and  ||| S:1124 E:1128 ||| CC
controls ||| S:1128 E:1136 ||| NNS
.  ||| S:1136 E:1138 ||| .
Receiver  ||| S:1138 E:1147 ||| NN
operating  ||| S:1147 E:1157 ||| VBG
characteristic  ||| S:1157 E:1172 ||| JJ
curves  ||| S:1172 E:1179 ||| NNS
determined  ||| S:1179 E:1190 ||| VBN
pkS  ||| S:1190 E:1194 ||| JJ
values  ||| S:1194 E:1201 ||| NNS
with  ||| S:1201 E:1206 ||| IN
highest  ||| S:1206 E:1214 ||| JJS
sensitivity  ||| S:1214 E:1226 ||| NN
and  ||| S:1226 E:1230 ||| CC
specificity  ||| S:1230 E:1242 ||| NN
for  ||| S:1242 E:1246 ||| IN
concurrent  ||| S:1246 E:1257 ||| JJ
troponin  ||| S:1257 E:1266 ||| JJ
leak  ||| S:1266 E:1271 ||| NN
and  ||| S:1271 E:1275 ||| CC
LGE ||| S:1275 E:1278 ||| NNP
.  ||| S:1278 E:1280 ||| .
FT  ||| S:1280 E:1283 ||| NNP
was  ||| S:1283 E:1287 ||| VBD
performed  ||| S:1287 E:1297 ||| VBN
on  ||| S:1297 E:1300 ||| IN
57  ||| S:1300 E:1303 ||| CD
patients ||| S:1303 E:1311 ||| NNS
:  ||| S:1311 E:1313 ||| :
37  ||| S:1313 E:1316 ||| CD
MYO  ||| S:1316 E:1320 ||| NNP
and  ||| S:1320 E:1324 ||| CC
20  ||| S:1324 E:1327 ||| CD
controls ||| S:1327 E:1335 ||| NNS
.  ||| S:1335 E:1337 ||| .
Twenty-eight  ||| S:1337 E:1350 ||| JJ
cases  ||| S:1350 E:1356 ||| NNS
with  ||| S:1356 E:1361 ||| IN
normal  ||| S:1361 E:1368 ||| JJ
EF ||| S:1368 E:1370 ||| NNP
,  ||| S:1370 E:1372 ||| ,
and  ||| S:1372 E:1376 ||| CC
20  ||| S:1376 E:1379 ||| CD
control  ||| S:1379 E:1387 ||| NN
patients  ||| S:1387 E:1396 ||| NNS
were  ||| S:1396 E:1401 ||| VBD
included  ||| S:1401 E:1410 ||| VBN
in  ||| S:1410 E:1413 ||| IN
final  ||| S:1413 E:1419 ||| JJ
analysis ||| S:1419 E:1427 ||| NN
.  ||| S:1427 E:1429 ||| .
Nearly  ||| S:1429 E:1436 ||| RB
all  ||| S:1436 E:1440 ||| DT
cases  ||| S:1440 E:1446 ||| NNS
with  ||| S:1446 E:1451 ||| IN
normal  ||| S:1451 E:1458 ||| JJ
function  ||| S:1458 E:1467 ||| NN
demonstrated  ||| S:1467 E:1480 ||| VBD
abnormal  ||| S:1480 E:1489 ||| JJ
regional  ||| S:1489 E:1498 ||| JJ
pkS  ||| S:1498 E:1502 ||| NN
( ||| S:1502 E:1503 ||| -LRB-
27 ||| S:1503 E:1505 ||| CD
/ ||| S:1505 E:1506 ||| CD
28 ||| S:1506 E:1508 ||| CD
,  ||| S:1508 E:1510 ||| ,
96  ||| S:1510 E:1513 ||| CD
% ||| S:1513 E:1514 ||| NN
) ||| S:1514 E:1515 ||| -RRB-
.  ||| S:1515 E:1517 ||| .
Cases  ||| S:1517 E:1523 ||| NNS
had  ||| S:1523 E:1527 ||| VBD
significantly  ||| S:1527 E:1541 ||| RB
diminished  ||| S:1541 E:1552 ||| VBN
pkS  ||| S:1552 E:1556 ||| JJ
when  ||| S:1556 E:1561 ||| WRB
compared  ||| S:1561 E:1570 ||| VBN
to  ||| S:1570 E:1573 ||| TO
controls  ||| S:1573 E:1582 ||| NNS
in  ||| S:1582 E:1585 ||| IN
all  ||| S:1585 E:1589 ||| DT
regions  ||| S:1589 E:1597 ||| NNS
except  ||| S:1597 E:1604 ||| IN
the  ||| S:1604 E:1608 ||| DT
longitudinal  ||| S:1608 E:1621 ||| JJ
2C  ||| S:1621 E:1624 ||| CD
distribution ||| S:1624 E:1636 ||| NN
.  ||| S:1636 E:1638 ||| .
FT-derived  ||| S:1638 E:1649 ||| JJ
longitudinal  ||| S:1649 E:1662 ||| NN
and  ||| S:1662 E:1666 ||| CC
circumferential  ||| S:1666 E:1682 ||| JJ
pkS  ||| S:1682 E:1686 ||| NN
is  ||| S:1686 E:1689 ||| VBZ
sensitive  ||| S:1689 E:1699 ||| JJ
and  ||| S:1699 E:1703 ||| CC
specific  ||| S:1703 E:1712 ||| JJ
in  ||| S:1712 E:1715 ||| IN
identifying  ||| S:1715 E:1727 ||| VBG
myocardial  ||| S:1727 E:1738 ||| JJ
involvement ||| S:1738 E:1749 ||| NN
,  ||| S:1749 E:1751 ||| ,
namely  ||| S:1751 E:1758 ||| RB
the  ||| S:1758 E:1762 ||| DT
presence  ||| S:1762 E:1771 ||| NN
of  ||| S:1771 E:1774 ||| IN
troponin  ||| S:1774 E:1783 ||| JJ
leak  ||| S:1783 E:1788 ||| NN
and  ||| S:1788 E:1792 ||| CC
LGE ||| S:1792 E:1795 ||| NNP
.  ||| S:1795 E:1797 ||| .
FT  ||| S:1797 E:1800 ||| NNP
may  ||| S:1800 E:1804 ||| MD
be  ||| S:1804 E:1807 ||| VB
a  ||| S:1807 E:1809 ||| DT
useful  ||| S:1809 E:1816 ||| JJ
adjunctive ||| S:1816 E:1826 ||| NN
,  ||| S:1826 E:1828 ||| ,
objective  ||| S:1828 E:1838 ||| JJ
measure  ||| S:1838 E:1846 ||| NN
of  ||| S:1846 E:1849 ||| IN
myocardial  ||| S:1849 E:1860 ||| JJ
involvement  ||| S:1860 E:1872 ||| NN
in  ||| S:1872 E:1875 ||| IN
patients  ||| S:1875 E:1884 ||| NNS
with  ||| S:1884 E:1889 ||| IN
MYO  ||| S:1889 E:1893 ||| NNP
and  ||| S:1893 E:1897 ||| CC
normal  ||| S:1897 E:1904 ||| JJ
LV  ||| S:1904 E:1907 ||| NNP
function ||| S:1907 E:1915 ||| NN
.  ||| S:1915 E:1917 ||| .
